Schwendener R A, Trüb T, Schott H, Langhals H, Barth R F, Groscurth P, Hengartner H
Department of Experimental Pathology, University Hospital, Zürich, Switzerland.
Biochim Biophys Acta. 1990 Jul 9;1026(1):69-79. doi: 10.1016/0005-2736(90)90334-k.
The two coupling agents SPDP (N-succinimidyl-3-(2-pyridyldithio)propionate) and SATA (N-succinimidyl-S-acetylthioacetate) were compared in their efficiency and feasibility to couple monoclonal antibodies (Abs) via thioether linkage to liposomes functionalized by various lipophilic maleimide compounds like N-(3-maleimidopropionyl)-N2-palmitoyl-L-lysine methyl ester (MP-PL), N-(3-maleimidopropionyl)phosphatidylethanolamide (MP-PE), N6-(6-maleimidocaproyl)-N2-palmitoyl-L-lysine methyl ester (EMC-PL), and N-(6-maleimidocaproyl)phosphatidylethanolamine (EMC-PE). The composition of the liposomes was soy phosphatidylcholine (SPC), cholesterol, maleimide compounds and alpha-tocopherol (1:0.2:0.02:0.01, mol parts), plus N4-oleylcytosine arabinoside (NOAC) as cytostatic prodrug (0.2 mol parts) and a new, lipophilic and highly fluorescent dye N,N'-bis(1-hexylhfetyl)-3,4:9,10-perylenebis(dicarboximid ) (BHPD, 0.006 mol parts). From the maleimide derivatives MP-PL was the most effective in terms of preservation of the coupling activity in dependence of liposome storage. The coupling of the monoclonal A B8-24.3 (mouse IgG2b, MHC class I, anti H-2kb) and IB16-6 (rat IgG2a, anti B16 mouse melanoma) to the drug carrying liposomes was more effective and easier to accomplish with SATA as compared to SPDP. Coupling rates of 60-65% were obtained with SATA at molar ratios of 12 SATA:1 Ab:40 maleimide spacer groups on the surface of one liposome. The highest coupling rates with SPDP were obtained at the ratio of 24 SPDP:1 Ab:40 liposomal maleimide groups, with an Ab binding efficiency of only 20-25%. The optimal in vitro binding conditions to specific target cells (EL4 for B8-24.3-liposomes and B16-F10 for IB16-6-liposomes) were determined by cytofluorometric measurement of the liposomal BHPD fluorescence with SATA linked Abs. Optimal immunoliposome binding to specific epitopes on the target cells was achieved with 1-2 Ab molecules coupled to one liposome, with immunoliposome concentrations of 20-130 nM and with a small incubation volume of 0.3-0.4 ml. The specificity of the binding of B8-24.3-liposomes to EL4 target cells was visualized by scanning electron microscopy. Antibody mediated endocytic uptake of immunoliposomes could be demonstrated by transmission electron microscopy.
比较了两种偶联剂SPDP(N - 琥珀酰亚胺基 - 3 -(2 - 吡啶基二硫代)丙酸酯)和SATA(N - 琥珀酰亚胺基 - S - 乙酰硫代乙酸酯)通过硫醚键将单克隆抗体(Abs)偶联到由各种亲脂性马来酰亚胺化合物(如N -(3 - 马来酰亚胺丙酰基)- N2 - 棕榈酰 - L - 赖氨酸甲酯(MP - PL)、N -(3 - 马来酰亚胺丙酰基)磷脂酰乙醇胺(MP - PE)、N6 -(6 - 马来酰亚胺己酰基)- N2 - 棕榈酰 - L - 赖氨酸甲酯(EMC - PL)和N -(6 - 马来酰亚胺己酰基)磷脂酰乙醇胺(EMC - PE))功能化的脂质体上的效率和可行性。脂质体的组成是大豆磷脂酰胆碱(SPC)、胆固醇、马来酰亚胺化合物和α - 生育酚(1:0.2:0.02:0.01,摩尔比),加上N4 - 油酰基胞嘧啶阿拉伯糖苷(NOAC)作为细胞抑制前药(0.2摩尔比)和一种新的亲脂性高荧光染料N,N'-双(1 - 己基己基)- 3,4:9,10 - 苝二(二甲酰亚胺)(BHPD,0.006摩尔比)。在脂质体储存依赖的偶联活性保存方面,马来酰亚胺衍生物MP - PL是最有效的。与SPDP相比,单克隆抗体A B8 - 24.3(小鼠IgG2b,MHC I类,抗H - 2kb)和IB16 - 6(大鼠IgG2a,抗B16小鼠黑色素瘤)与载药脂质体的偶联使用SATA更有效且更容易完成。在一个脂质体表面的摩尔比为12 SATA:1 Ab:40马来酰亚胺间隔基团时,SATA的偶联率为60 - 65%。使用SPDP时,在24 SPDP:1 Ab:40脂质体马来酰亚胺基团的比例下获得最高偶联率,抗体结合效率仅为20 - 25%。通过细胞荧光测量与SATA连接的抗体的脂质体BHPD荧光,确定了与特定靶细胞(B8 - 24.3 - 脂质体的EL4和IB16 - 6 - 脂质体的B16 - F10)的最佳体外结合条件。每个脂质体偶联1 - 2个抗体分子、免疫脂质体浓度为20 - 130 nM且孵育体积小至0.3 - 0.4 ml时,可实现免疫脂质体与靶细胞上特定表位的最佳结合。通过扫描电子显微镜观察到B8 - 24.3 - 脂质体与EL4靶细胞结合的特异性。通过透射电子显微镜可证明抗体介导的免疫脂质体内吞摄取。